Skip to main content
Log in

Tumor suppressor genes and medulloblastoma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Although primary intracranial neoplasms are the most common type of solid cancer in children, little is known about their etiology at the molecular genetic level. Recently, studies have shown that a class of genes known as tumor suppressors play an important role in the origin of several different types of human tumors, including those located in the central nervous system (CNS). Using a variety of techniques, selective loss of DNA sequences has been identified in tissue specimens from children with medulloblastoma, one of the most common pediatric brain tumors. The most consistent losses to date have been shown for probes located on distal chromosome arm 17p. Although the known tumor suppressor p53 is located on this chromosome, and deletion and mutation of the p53 gene are the most common genetic events in human cancers of many types, such alterations have been infrequently detected in medulloblastoma specimens. These results suggest that inactivation of another tumor suppressor gene or genes located on 17p is important in medulloblastoma tumorigenesis. Deletion of 17p has also been shown to have implications for clinical management, as the loss of DNA sequences located on this chromosome arm is strongly associated with a negative prognosis for these patients. The identification and cloning of this tumor suppressor gene or genes will aid in understanding of the pathogenesis of medulloblastoma, as well as guiding the development of novel and more effective strategies for a cure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Belza MG, Donaldson SS, Steinberg GK: Medulloblastoma: freedom from relapse longer than 8 years — a therapeutic cure? JNS 75: 575–582, 1991

    Google Scholar 

  2. Friend SH, Dryja TP, Weinberg RA: Oncogenes and tumor-suppressing genes. NEJM 318: 618–622, 1988

    Google Scholar 

  3. Griffen CA, Hawkins AL, Packer RJ: Chromosome abnormalities in pediatric brain tumors. Cancer Res 48: 175–180, 1988

    Google Scholar 

  4. Bigner SH, Friedman HS, Biegel JA: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30: 91–101, 1988

    Google Scholar 

  5. Thomas GA, Raffel C: Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51: 639–643, 1991

    Google Scholar 

  6. Cogen PH, Daneshvar L, Metzger AK: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8: 279–285, 1990

    Google Scholar 

  7. Biegel JA, Burk CD, Barr FG: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52: 3391–3395, 1992

    Google Scholar 

  8. James CD, He J, Carlbom E: Loss of genetic information in central nervous system tumors common to children and young adults. Genes, Chrom, Cancer 2:1990

  9. McDonald J, Daneshvar L, Willert JR: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229–232, 1994

    Google Scholar 

  10. Knudsen AJ Jr: Mutation and cancer: Statistical study of retinoblastoma. PNAS 68: 820–823, 1971

    Google Scholar 

  11. Sparkes RS, Sparkes MC, Wilson MG: Regional assignment of genes for esterase D and retinoblastoma to chromosome band 13g14. Sci 208: 1042–1044, 1980

    Google Scholar 

  12. Cavenee WK, Dryja TP, Phillips NA: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779–784, 1983

    Google Scholar 

  13. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: A laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor, NY, 1989

    Google Scholar 

  14. Friend SH, Bernards S, Rogelj S: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 313: 101–106, 1985

    Google Scholar 

  15. Lee W-H, Shew J-Y, Hong FD: Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Nature 329: 642–645, 1987

    Google Scholar 

  16. Harbour JW Lai S-L, Whang-Peng J: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Sci 241: 353–357, 1988

    Google Scholar 

  17. Call KM, Glaser T, Ito C: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509–520, 1990

    Google Scholar 

  18. Kinzler KW, Nilbert MC, Vogelstein B: Identification of a gene located at chromosome 5821 that is mutated in colorectal cancers. Sci 251: 1366–1371, 1991

    Google Scholar 

  19. Marchuk DA, Saulino AM, Tavvakol R: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF gene product. Genomics 11: 931–940, 1991

    Google Scholar 

  20. Rouleau GA, Merel P, Lutchman M: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515–522, 1993

    Google Scholar 

  21. Miki Y, Swensen J, Shattuck-Eidens D: A strong candicate for the breast and ovarian cancer susceptibility gene BRCA1. Sci 266: 66–72, 1994

    Google Scholar 

  22. Kamb A, Gruis NA, Weaver-Feldhaus J: A cell cycle regulator potentially involved in genesis of many tumor types. Sci 264: 436–440, 1994

    Google Scholar 

  23. Soussi T, de Fromentel CC, May P: Structural aspects of the p53 protein in relation to gene evolution. Oncogenes 5: 945–952, 1990

    Google Scholar 

  24. Lamb P, Crawford L: Characterization of the human p53 gene. Mol Cell Biol 6: 1379–1385, 1986

    Google Scholar 

  25. Baker SJ, Fearon ER, Nigro JM: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Sci 244: 217–221, 1989

    Google Scholar 

  26. Nigro JM, Baker SJ, Preisinger AC: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705–708, 1989

    Google Scholar 

  27. Metzger AK, Sheffield VC, Duyk G: Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. PNAS 88: 7825–7829, 1991

    Google Scholar 

  28. Sidransky D, Mikkelsen T, Schwechheimer K: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355: 846–847, 1992

    Google Scholar 

  29. Hollstein M, Sidransky D, Vogelstein B: p53 mutations in human cancers. Sci 253: 49–54, 1991

    Google Scholar 

  30. Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes, Chrom, Cancer 10: 221–230, 1994

    Google Scholar 

  31. Cogen PH, Daneshvar L, Metzger AK: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 50: 584–589, 1992

    Google Scholar 

  32. Sheffield VC, Cox DR, Lerman LS: Attachment of a 40-base-pair G + C-rich sequence (GC clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single base-pair changes. PNAS 86: 232–236, 1989

    Google Scholar 

  33. Saylors RL, Sidransky D, Friedman HS: Infrequent p53 mutations in medulloblastoma. Cancer Res 51: 4721–4723, 1991

    Google Scholar 

  34. Adesina A, Nalbantoglu J, Cavenee WK: p53 mutation and MDM2 gene amplification are uncommon in medulloblastoma. Cancer Res 51: 5649–5651, 1994

    Google Scholar 

  35. Ohgaki H, Eibl RH, Wiestler D: p53 mutations in nonastrocytic human brain tumors. Cancer Res 51: 6202–6205, 1991

    Google Scholar 

  36. Coles C, Thompson AM, Elder PA: Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 336: 761–763, 1990

    Google Scholar 

  37. DiSilvestre D, Morris C, Heisterkamp N: A second hypervariable RFLP within the ABR gene. Nucl Acids Res 18: 5925, 1990

    Google Scholar 

  38. Seeger RC: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. NEJM 313: 1111–1116, 1985

    Google Scholar 

  39. Kopelson G, Linggold RM, Kleinman GM: Medulloblastoma: The identification of prognostic subgroups and implications of multimodality management. Cancer 51: 312–320, 1983

    Google Scholar 

  40. Cogen PH: Prognostic signifcance of molecular genetic markers in childhood brain tumors. Ped Neurosurg 17: 245–250, 1991–1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cogen, P.H., McDonald, J.D. Tumor suppressor genes and medulloblastoma. J Neuro-Oncol 29, 103–112 (1996). https://doi.org/10.1007/BF00165523

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165523

Key words

Navigation